VANCOUVER, July 17, 2019 /CNW/ - PRESS RELEASE - Harvest One Cannabis Inc. has announced that the company, through its wholly-owned subsidiary, Satipharm Ltd., has entered into a supply agreement with GenCanna Global USA dated June 4, 2019. Under the terms of the agreement, GenCanna will supply Harvest One with GMP Certified CBD oil and finished products for distribution in regulated markets in the United States, Europe and around the globe, currently under the Dream Water, Satipharm and LivRelief brands for an initial term of two years. In addition, GenCanna will support the company in the research, development and formulation of both existing and new CBD-infused products.
With 38,000-plus retail distribution points around the globe (including, Walmart U.S., CVS, Kroger, Shoppers Drug Mart, Loblaw, Holland & Barrett and Boots), Harvest One is quickly becoming a global house of brands in the health, wellness and self-care sectors, with cannabis, cannabis-infused and all-natural product offerings. From Satipharm's patented GelPell CBD capsules to Dream Water's all natural, single shot sleep products, and the recent addition of LivRelief, an all natural topical pain relief cream in Canada, the agreement with GenCanna ensures the consistent supply of premium quality hemp-derived CBD for infusion of existing products and further product innovation.
"Working with world-class partners like GenCanna to supply premium quality, traceable, consistent ingredients, all from GMP-certified facilities, is critical to our core strategy at Harvest One to only offer consumers best-in-class premium products, with consistent and predictable effects, in delivery formats they have come to understand and demand," said Grant Froese, chief executive officer of Harvest One. "This agreement signals the beginning of a global relationship with GenCanna under which we will continue to innovate, infuse our existing portfolio of products, and bring new products to market under our well-recognized and trusted, Satipharm, Dream Water and LivRelief brands."
"Our evolving relationship with Harvest One reflects both companies' devotion to consumer product quality," said Steve Bevan, executive chair of GenCanna. "Joint research and development have combined to provide excellent CBD product additions to Harvest One's suite of leading-edge brands. We expect that consumers will quickly welcome these products on retail shelves globally."
Under the terms of the agreement, GenCanna will provide a production platform that uses proprietary harvesting and crop processing technologies that produce purity and quality. This will allow Harvest One and their brands around the world to access a consistent and fully compliant stable supply of hemp-derived CBD extract and products that consumers and patients can count on.
